As of 2025-06-03, the EV/EBITDA ratio of PuraPharm Corp Ltd (1498.HK) is 12.46. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 1498.HK's latest enterprise value is 552.87 mil HKD. 1498.HK's TTM EBITDA according to its financial statements is 44.36 mil HKD. Dividing these 2 quantities gives us the above 1498.HK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative Enterprise Value.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 7.5x | 7.4x |
| Forward P/E multiples | 3.8x - 5.5x | 4.4x |
| Fair Price | (0.68) - (0.04) | (0.36) |
| Upside | -233.7% - -108.2% | -169.8% |
| Date | EV/EBITDA |
| 2025-06-02 | 12.46 |
| 2025-05-30 | 12.37 |
| 2025-05-29 | 12.33 |
| 2025-05-28 | 12.29 |
| 2025-05-27 | 12.29 |
| 2025-05-26 | 12.29 |
| 2025-05-23 | 12.55 |
| 2025-05-22 | 12.46 |
| 2025-05-21 | 12.46 |
| 2025-05-20 | 12.73 |
| 2025-05-19 | 12.37 |
| 2025-05-16 | 12.20 |
| 2025-05-15 | 12.29 |
| 2025-05-14 | 12.15 |
| 2025-05-13 | 12.24 |
| 2025-05-12 | 12.20 |
| 2025-05-09 | 12.20 |
| 2025-05-08 | 12.20 |
| 2025-05-07 | 12.20 |
| 2025-05-06 | 12.15 |
| 2025-05-02 | 12.15 |
| 2025-04-30 | 12.15 |
| 2025-04-29 | 12.15 |
| 2025-04-28 | 12.24 |
| 2025-04-25 | 12.24 |
| 2025-04-24 | 12.24 |
| 2025-04-23 | 12.11 |
| 2025-04-22 | 12.11 |
| 2025-04-17 | 12.11 |
| 2025-04-16 | 12.20 |
| 2025-04-15 | 12.29 |
| 2025-04-14 | 12.29 |
| 2025-04-11 | 12.33 |
| 2025-04-10 | 12.37 |
| 2025-04-09 | 12.46 |
| 2025-04-08 | 12.37 |
| 2025-04-07 | 12.37 |
| 2025-04-03 | 12.82 |
| 2025-04-02 | 13.09 |
| 2025-04-01 | 13.18 |
| 2025-03-31 | 13.00 |
| 2025-03-28 | 13.27 |
| 2025-03-27 | 13.09 |
| 2025-03-26 | 12.91 |
| 2025-03-25 | 12.91 |
| 2025-03-24 | 13.00 |
| 2025-03-21 | 13.00 |
| 2025-03-20 | 12.64 |
| 2025-03-19 | 12.82 |
| 2025-03-18 | 12.91 |